Upper Limb Strength and Function Changes during a One-Year Follow-Up in Non-Ambulant Patients with Duchenne Muscular Dystrophy: An Observational Multicenter Trial

6 Minute Walk Test in Duchenne MD Patients with Different Mutations: 12 Month Changes

(2014) Marika Pane et al.   PLoS One

Eteplirsen for the treatment of Duchenne muscular dystrophy

(2013) Jerry R. Mendell et al.   ANNALS OF NEUROLOGY

Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy

(2013) Anna Mayhew et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Muscular dystrophies

(2013) Eugenio Mercuri et al.   LANCET

THE 6-minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter study

(2013) Craig M. Mcdonald et al.   MUSCLE & NERVE

The cooperative international neuromuscular research group Duchenne natural history study: Glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and othe

(2013) Erik K. Henricson et al.   MUSCLE & NERVE

P.2.4 Upper extremity reachable workspace evaluation in DMD using Kinect

(2013) G. Kurillo et al.   NEUROMUSCULAR DISORDERS

Early neurodevelopmental assessment in Duchenne muscular dystrophy

(2013) Marika Pane et al.   NEUROMUSCULAR DISORDERS

Responsiveness of the Motor Function Measure in Neuromuscular Diseases

(2012) Carole Vuillerot et al.   ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures

(2012) Alberto Lerario et al.   BMC Neurology

A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy

(2012) ELENA S MAZZONE et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

International workshop on assessment of upper limb function in Duchenne Muscular Dystrophy

(2012) Eugenio Mercuri et al.   NEUROMUSCULAR DISORDERS

Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients

(2012) L. Servais et al.   NEUROMUSCULAR DISORDERS

Development and Application of Stereo Camera-Based Upper Extremity Workspace Evaluation in Patients with Neuromuscular Diseases

(2012) Gregorij Kurillo et al.   PLoS One

Motor and respiratory heterogeneity in Duchenne patients: Implication for clinical trials

(2011) Véronique Humbertclaude et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Upper limb function in adults with Duchenne muscular dystrophy

(2011) RF Pangalila et al.   JOURNAL OF REHABILITATION MEDICINE

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

(2011) Sebahattin Cirak et al.   LANCET

Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: Results from a 12 month, double-blind, randomized placebo-controlled trial

(2011) Gunnar M. Buyse et al.   NEUROMUSCULAR DISORDERS

Assessing upper limb function in nonambulant SMA patients: Development of a new module

(2011) Elena Mazzone et al.   NEUROMUSCULAR DISORDERS

Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy

(2011) Nathalie M. Goemans et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Natural History of Cardiac and Pulmonary Function Decline in Patients With Duchenne Muscular Dystrophy

(2011) Rolando Roberto et al.   SPINE

Impact of Steroids on Surgical Experiences of Patients With Duchenne Muscular Dystrophy

(2010) Joseph M. Dooley et al.   PEDIATRIC NEUROLOGY

Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression

(2009) F. Daoud et al.   HUMAN MOLECULAR GENETICS

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

(2009) Katharine Bushby et al.   LANCET NEUROLOGY

Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care

(2009) Katharine Bushby et al.   LANCET NEUROLOGY

The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy

(2009) Craig M. McDonald et al.   MUSCLE & NERVE

Clinical Heterogeneity of Duchenne Muscular Dystrophy (DMD): Definition of Sub-Phenotypes and Predictive Criteria by Long-Term Follow-Up

(2009) Isabelle Desguerre et al.   PLoS One

Hand weakness in Duchenne muscular dystrophy and its relation to physical disability

(2008) Fabiana Luisa Mattar et al.   NEUROMUSCULAR DISORDERS

Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; Report of three expert workshops: TREAT-NMD/ENMC Workshop on outcome measures, 12th–13th May 2007, Naarden, The Netherlands; TREAT-NMD Workshop on outcome measures in experimental trials for DMD, 30th June–1st July 2007, Naarden, The Netherlands; Conjoint Institute of Myology TREAT-NMD Meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France

(2008) E. Mercuri et al.   NEUROMUSCULAR DISORDERS